Go Pro
→ These gold assets are priced for $1,800 gold [it's over $4,000] (From Golden Portfolio) (Ad)tc pixel
NASDAQ:PLUR

Pluri Q3 2025 Earnings Report

Pluri logo
$1.05 -0.01 (-0.94%)
Closing price 04:00 PM Eastern
Extended Trading
$1.02 -0.03 (-2.38%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

Pluri EPS Results

Actual EPS
-$0.94
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Pluri Revenue Results

Actual Revenue
$0.43 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Pluri Announcement Details

Quarter
Q3 2025
Date
5/13/2025
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Pluri's next earnings date is estimated for Thursday, November 5, 2026, based on past reporting schedules.

Conference Call Resources

Pluri Earnings Headlines

iBio (NASDAQ:IBIO) & Pluri (NASDAQ:PLUR) Financial Contrast
September 21 at 4:45 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31036557
Pluri (PLUR) to Release Quarterly Earnings on Wednesday
September 16, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31025609
Buffett's Final Warning: "The Dollar Is Going to Hell"
On May 3rd, 2025, Warren Buffett looked at his shareholders for the last time and said: "The dollar is going to hell." Ray Dalio agrees. The founder of Bridgewater Associates ($150 billion AUM) calls it a "debt death spiral." But there's a specific asset class and investment system that actually thrives when the dollar collapses.tc pixel
September 24 at 1:00 AM  |  Decentralized Masters (Ad)
Pluri Inc. Reports Earnings Results for the Full Year Ended June 30, 2026
September 10, 2026  |  marketscreener.comM
Pluri Announces August 2026 Equity Financing Transaction
August 28, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/pluri-announces-august-2026-equity-financing-transaction?utm_source=marketbeat.com&utm_medium=referral
Pluri prices $3.3 million offering
August 27, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4637455-pluri-prices-33-million-offering
See More Pluri Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Pluri? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Pluri and other key companies, straight to your email.

About Pluri

Pluri (NASDAQ:PLUR) Ltd. is an Israel-based biotechnology company that develops cell-based products using its proprietary three-dimensional cell expansion technology. The platform is designed to produce large quantities of potentially therapeutic and commercial cells while maintaining consistent quality and scalability.

The company’s research and development activities have included placenta-derived, off-the-shelf cell therapies, historically marketed under the PLX platform. These programs have targeted areas such as regenerative medicine, inflammation, cancer, orthopedic conditions and other medical needs. Pluri has also expanded its technology applications into areas including cell-based food and other non-pharmaceutical products.

Founded as Pluristem Therapeutics, the company adopted the name Pluri Ltd. in 2022. It is headquartered in Haifa, Israel, and develops its products for potential use in global healthcare and biotechnology markets through research programs and strategic collaborations. Yaky Yanay serves as the company’s chief executive officer.

View Pluri Profile
Earnings Tools